• Education
  •  Download App
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The CIMS logo.
  • Home
  • Find Drugs
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The CIMS logo.
  • Home
  • Find Drugs
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The CIMS logo.
Home
Find Drugs
Find Drug Company
Diseases
Medical News & Updates

Other Services
 Education
  Download App
Country
singapore
hong kong
malaysia
indonesia
thailand
philippines
vietnam
australia
korea
new zealand
Account
The CIMS logo.
  1. Medical News & Updates
  2. ...
    • Medical News & Updates
  3. List of News & Updates

News & Updates

A red magnifying glass.
Search
Filter by Specialty:
CardiologyMultidisciplinaryDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy
CardiologyMultidisciplinaryDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy

Filters

Specialty:
CardiologyMultidisciplinaryDermatologyEndocrinologyGastroenterologyHepatologyInfectious DiseasesNeurologyObstetrics & GynaecologyOncologyOphthalmologyPaediatricsPsychiatryRespirologyRheumatologyUrologyPharmacy
Show Multimedia Only
Continuous flow ventricular assist devices do not worsen GI bleeding risk
Continuous flow ventricular assist devices do not worsen GI bleeding risk
03 Sep 2020

The use of continuous flow ventricular assist devices (VADs), regardless of the type, does not appear to exacerbate the risk of gastrointestinal bleeding (GIB), according to a recent meta-analysis.

Continuous flow ventricular assist devices do not worsen GI bleeding risk
03 Sep 2020
Lower CRC risk with ACEis, ARBs?
Lower CRC risk with ACEis, ARBs?
01 Sep 2020 byRoshini Claire Anthony
Roshini Claire Anthony

The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) may be associated with a reduced risk of colorectal cancer (CRC), according to a retrospective cohort study from Hong Kong.

Lower CRC risk with ACEis, ARBs?
01 Sep 2020
  • 253
  • 254
  • 255
The CIMS logo.
  • Drugs
  • Find Drugs
  • Find Drug Company
  • CIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with CIMS
A social media brand icon.A social media brand icon.A social media brand icon.A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
CIMS Specialty v3.3.0
Copyright © 2025 CIMS Pte Ltd. All rights reserved. PRD
CIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.